Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Pollen Allergenic Extract [EPC]
Canis Lupus Familiaris Skin is a standardized or non-standardized allergenic extract used for the diagnosis and treatment of dog-related allergies. It belongs to the class of allergenic extracts used in subcutaneous immunotherapy (SCIT).
Name
Canis Lupus Familiaris Skin
Raw Name
CANIS LUPUS FAMILIARIS SKIN
Category
Standardized Pollen Allergenic Extract [EPC]
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Canis Lupus Familiaris Skin
Canis Lupus Familiaris Skin is a standardized or non-standardized allergenic extract used for the diagnosis and treatment of dog-related allergies. It belongs to the class of allergenic extracts used in subcutaneous immunotherapy (SCIT).
Detailed information about Canis Lupus Familiaris Skin
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Canis Lupus Familiaris Skin.
Canis Lupus Familiaris Skin refers to a pharmaceutical-grade allergenic extract derived from the epithelial tissue (skin) and dander of the domestic dog (Canis lupus familiaris). This biological product belongs to a broad pharmacological class known as Standardized or Non-Standardized Animal Skin Allergenic Extracts [EPC]. These extracts are utilized by healthcare providers, specifically board-certified allergists and immunologists, to diagnose and treat Type I hypersensitivities (immediate-type allergic reactions) triggered by exposure to canine allergens. The FDA has regulated these extracts for decades, ensuring that they contain specific concentrations of allergenic proteins, such as Can f 1 and Can f 2, which are the primary secretoglobins and lipocalins responsible for dog allergies in humans.
In clinical practice, Canis Lupus Familiaris Skin is administered through two primary modalities: in-vivo diagnostic testing (skin prick or intradermal testing) and allergen immunotherapy (often referred to as 'allergy shots'). When used for immunotherapy, the goal is to induce 'desensitization' or 'immunological tolerance,' effectively retraining the patient's immune system to stop overreacting to dog dander. This drug is not a medication that provides immediate symptom relief like an antihistamine; rather, it is a disease-modifying biological therapy that addresses the underlying cause of the allergic disease.
The mechanism of action for Canis Lupus Familiaris Skin is complex and involves a multi-step modulation of the human immune system. At the molecular level, the extract introduces controlled amounts of dog-specific proteins to the patient's immune cells. In a person with a dog allergy, the immune system incorrectly identifies these harmless proteins as dangerous pathogens, producing Immunoglobulin E (IgE) antibodies. These IgE antibodies bind to mast cells and basophils. Upon subsequent exposure to a dog, the allergen cross-links the IgE on these cells, causing the release of inflammatory mediators like histamine, leukotrienes, and prostaglandins, which result in sneezing, itching, and asthma.
When administered as immunotherapy, Canis Lupus Familiaris Skin works by shifting the immune response from a Th2-dominated profile (pro-allergic) to a Th1-dominated or T-regulatory (Treg) profile. This process involves the induction of 'blocking antibodies' known as Immunoglobulin G4 (IgG4). These IgG4 antibodies compete with IgE for binding to the dog allergens, effectively intercepting the allergen before it can trigger mast cell degranulation. Furthermore, the therapy promotes the secretion of anti-inflammatory cytokines such as Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), which suppress the allergic cascade and reduce tissue-specific inflammation in the nose, eyes, and lungs.
The pharmacokinetics of allergenic extracts like Canis Lupus Familiaris Skin differ significantly from traditional small-molecule drugs (like ibuprofen or lisinopril). Because these are complex mixtures of proteins and glycoproteins, they do not follow standard absorption, distribution, metabolism, and excretion (ADME) pathways.
Canis Lupus Familiaris Skin is FDA-approved for the following clinical indications:
Off-label uses are rare but may include experimental protocols for rapid desensitization (rush immunotherapy) in specific clinical settings, though this carries a higher risk of adverse events.
Canis Lupus Familiaris Skin is available in the following dosage forms:
> Important: Only your healthcare provider can determine if Canis Lupus Familiaris Skin is right for your specific condition. The selection of the appropriate concentration and dosing schedule requires specialized medical expertise.
The dosage for Canis Lupus Familiaris Skin is highly individualized and is determined by the patient's level of sensitivity, which is established through skin testing. There is no 'one-size-fits-all' dose. The treatment is divided into two distinct phases:
Canis Lupus Familiaris Skin is approved for use in children, typically those aged 5 years and older. The dosing logic is identical to that of adults, based on the child's specific sensitivity and the clinician's assessment. Because children may have a more reactive immune system, the buildup phase may sometimes be more gradual. Use in children under the age of 5 is generally avoided due to the difficulty of the child communicating early symptoms of a systemic reaction (anaphylaxis).
No dosage adjustments are required for patients with renal impairment, as the extract is not cleared by the kidneys in a way that affects systemic toxicity.
No dosage adjustments are required for patients with hepatic impairment.
Caution is advised in elderly patients (over 65). While the dose remains the same, the risk-benefit ratio must be carefully considered. Older adults are more likely to have underlying cardiovascular disease, which can make a systemic allergic reaction (anaphylaxis) more dangerous and harder to treat with epinephrine.
Canis Lupus Familiaris Skin must ONLY be administered by a healthcare professional in a clinical setting equipped to treat anaphylaxis. It is never for self-administration at home.
If a dose is missed during the buildup phase, the next dose may need to be reduced or the previous dose repeated, depending on how much time has passed. If a dose is missed for more than 4 weeks during maintenance, the allergist will typically reduce the dose and gradually build it back up to ensure safety. Never attempt to 'double up' on doses to make up for a missed appointment.
An 'overdose' in the context of allergenic extracts usually refers to an injection of too much allergen or an injection into a blood vessel. Symptoms include severe local swelling, hives, wheezing, throat tightness, and a drop in blood pressure. Emergency measures include the immediate administration of intramuscular epinephrine (Adrenalin), antihistamines, corticosteroids, and intravenous fluids. If you suspect a reaction after leaving the clinic, seek emergency medical care immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular attendance is critical for the success and safety of the therapy.
Local reactions are the most common side effect of Canis Lupus Familiaris Skin injections. These occur at the site of the injection and are generally considered a normal part of the immune response.
> Warning: Stop taking Canis Lupus Familiaris Skin and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Canis Lupus Familiaris Skin, as the substance is a natural protein. However, long-term use can lead to a permanent change in the immune system's reactivity. In rare cases, patients may develop 'serum sickness-like' reactions (joint pain, fever, and rash), though this is extremely uncommon with modern purified extracts.
Canis Lupus Familiaris Skin, like all allergenic extracts, carries a FDA Black Box Warning regarding the risk of severe systemic reactions.
Report any unusual symptoms to your healthcare provider. Even a 'mild' systemic reaction (like itchy palms or hives) must be reported, as it may precede a more severe reaction at the next dose.
Before beginning treatment with Canis Lupus Familiaris Skin, it is vital to understand that this is a biological product designed to provoke an immune response. Safety is dependent on strict adherence to the administration protocol. Patients must be 'clinically stable' on the day of their injection. If you are experiencing an asthma flare-up, have a fever, or are feeling generally unwell, your injection should be postponed. Always inform your nurse or doctor of any reactions you had after your previous dose, even if they seemed minor.
No FDA black box warnings for Canis Lupus Familiaris Skin? No, this is incorrect. Allergenic extracts carry a prominent Black Box Warning. The warning emphasizes that Canis Lupus Familiaris Skin is not interchangeable with other extracts and that its use is associated with a risk of severe anaphylaxis. It specifies that clinicians must be prepared to manage life-threatening emergencies and that certain medications (like beta-blockers) can complicate the treatment of such emergencies.
Unlike many drugs, Canis Lupus Familiaris Skin does not require routine blood work (like liver or kidney function tests). Instead, monitoring is clinical:
Most patients can drive and operate machinery after their 30-minute observation period. However, if you experience any lightheadedness, fatigue, or 'brain fog' after your injection, you should avoid these activities until the symptoms resolve.
There is no direct chemical interaction between alcohol and Canis Lupus Familiaris Skin. However, alcohol consumption can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of allergen absorption or mask the early signs of an allergic reaction. It is generally recommended to avoid alcohol for several hours before and after your injection.
Discontinuing Canis Lupus Familiaris Skin does not require a tapering schedule. There is no 'withdrawal syndrome.' However, stopping the treatment prematurely (before 3 years) significantly increases the likelihood that your dog allergy symptoms will return. If you stop for several months and wish to restart, you cannot return to your previous dose; you must start over at a much lower, safer concentration.
> Important: Discuss all your medical conditions with your healthcare provider before starting Canis Lupus Familiaris Skin.
There are few drugs that are 'absolutely' contraindicated, but the following combination is highly discouraged:
Canis Lupus Familiaris Skin will directly affect the results of Allergy Skin Tests and Serum IgE (RAST) tests.
For each major interaction, the mechanism usually involves either a pharmacodynamic interaction (affecting how the body responds to the allergen or the rescue medication) rather than a pharmacokinetic interaction (affecting drug levels).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any new heart or blood pressure medications.
Conditions where Canis Lupus Familiaris Skin must NEVER be used include:
These conditions require a careful risk-benefit analysis by the specialist:
Patients allergic to dog skin/dander may also show sensitivity to other members of the Canidae family, such as wolves, coyotes, or foxes, due to the high conservation of the Can f 1 protein across these species. There is also a known cross-reactivity between dog dander and cat dander (Fel d 1) in some patients, as well as a rare cross-reactivity with human seminal fluid (prostatic specific antigen), although this is clinically distinct.
> Important: Your healthcare provider will evaluate your complete medical history, including your current lung function and heart health, before prescribing Canis Lupus Familiaris Skin.
Canis Lupus Familiaris Skin is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known if the extract can cause fetal harm.
There is no evidence that Canis Lupus Familiaris Skin allergenic proteins are excreted into human milk. Furthermore, these proteins would likely be digested in the infant's stomach. Immunotherapy is considered safe for breastfeeding mothers. No adverse effects on the nursing infant have been documented.
Immunotherapy with dog extract is widely used in the pediatric population.
Patients over the age of 65 can receive Canis Lupus Familiaris Skin, but the risks are higher.
No dose adjustments are necessary for patients with kidney disease. The proteins in the extract are broken down locally and do not rely on renal filtration for clearance. However, patients on dialysis should have their shots scheduled on non-dialysis days to avoid confusion between a dialysis reaction and an allergy shot reaction.
No dose adjustments are necessary for patients with liver disease. The liver is not involved in the primary metabolism of injected allergenic proteins.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health problems during the course of your treatment.
Canis Lupus Familiaris Skin works through immunological desensitization. The extract contains the major dog allergens: Can f 1 (a lipocalin), Can f 2, Can f 3 (dog serum albumin), and Can f 5 (a prostatic kallikrein).
Upon subcutaneous injection, these proteins are taken up by peripheral dendritic cells. These cells migrate to the lymph nodes and present the allergen to 'naive' T-cells. In an allergic person, these T-cells would normally become Th2 cells (which promote IgE). Immunotherapy forces these cells to become T-regulatory (Treg) cells. These Treg cells produce IL-10, which tells B-cells to stop making IgE and start making IgG4. IgG4 acts as a 'decoy' or 'blocking antibody.' When the patient later breathes in dog dander, the IgG4 grabs the allergen first, preventing it from reaching the IgE on the mast cells, thereby preventing the allergic reaction.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous biological) |
| Protein Binding | N/A (Processed by immune cells) |
| Half-life | Hours to days (Proteolytic degradation) |
| Tmax | 15-30 minutes (Peak local concentration) |
| Metabolism | Local proteolysis (proteases) |
| Excretion | Not renally excreted as intact drug |
Canis Lupus Familiaris Skin is classified as an Allergenic Extract. It is grouped with other animal dander extracts (Cat, Horse, Cow) and is distinct from pollen or mold extracts. It is a biological product regulated by the FDA's Center for Biologics Evaluation and Research (CBER).
Common questions about Canis Lupus Familiaris Skin
Canis Lupus Familiaris Skin is a medical extract used primarily for the diagnosis and treatment of dog allergies. In diagnostic settings, it is used in skin prick tests to confirm if a patient is allergic to dog dander by observing for a localized skin reaction. For treatment, it is used in allergen immunotherapy, commonly known as allergy shots, to help the body build a tolerance to dogs over time. This treatment is intended for patients who suffer from allergic rhinitis, conjunctivitis, or asthma triggered by canine exposure. It is not a quick-relief medication but a long-term therapy designed to modify the immune system's response.
The most frequent side effects are localized reactions at the site of the injection, occurring in nearly all patients at some point during therapy. These include redness, swelling, and itching that can range from the size of a mosquito bite to several centimeters in diameter. Some patients may also experience systemic symptoms like mild sneezing or nasal congestion shortly after the shot. While local reactions are generally harmless, they are carefully monitored by healthcare providers to determine if the next dose needs to be adjusted. More significant local swelling, often called a 'large local reaction,' may require the use of ice packs or over-the-counter antihistamines for comfort.
While there is no direct chemical interaction between alcohol and the dog allergenic extract, healthcare providers generally advise against consuming alcohol for several hours before and after an injection. Alcohol causes blood vessels to dilate (expand), which could theoretically speed up the absorption of the allergen into the bloodstream, increasing the risk of a systemic reaction. Additionally, being under the influence of alcohol may make it difficult for a patient to notice or accurately describe the early symptoms of anaphylaxis, such as itching or lightheadedness. For maximum safety, it is best to remain sober on the days you receive your immunotherapy injections. Always discuss your lifestyle habits with your allergist to ensure the safest treatment environment.
Canis Lupus Familiaris Skin is generally considered safe to continue during pregnancy if the patient is already on a stable maintenance dose and is tolerating it well. However, it is standard medical practice to avoid starting (initiating) the treatment during pregnancy due to the risk of anaphylaxis. If a pregnant woman were to have a severe allergic reaction to the shot, the resulting drop in blood pressure could reduce oxygen delivery to the fetus, posing a significant risk. If you become pregnant while receiving allergy shots, you must inform your allergist immediately. They will typically keep you at your current dose rather than increasing it, prioritizing the safety of both mother and baby throughout the pregnancy.
Immunotherapy with Canis Lupus Familiaris Skin is a slow process, and patients should not expect immediate relief from their dog allergies. Most individuals begin to notice a significant reduction in their symptoms and a decreased need for rescue medications after 6 to 12 months of consistent treatment. The full benefits of the therapy are usually realized after the patient has reached the maintenance phase, which involves higher concentrations of the extract. To achieve long-lasting or permanent results, the treatment must typically be continued for three to five years. Skipping doses or stopping early often results in the return of allergic symptoms, as the immune system has not been fully 'retrained.'
Yes, you can stop taking Canis Lupus Familiaris Skin injections at any time without experiencing physical withdrawal symptoms, as it is not an addictive substance. However, stopping the treatment abruptly, especially during the buildup phase or early in the maintenance phase, will likely result in the return of your dog allergy symptoms. The immunological changes induced by the shots require years of consistent exposure to become permanent. If you decide to stop treatment and then change your mind several months later, you will likely need to restart at a very low dose for safety reasons. It is always best to discuss your reasons for wanting to stop with your allergist to see if a different schedule might work for you.
If you miss a scheduled injection of Canis Lupus Familiaris Skin, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to take an extra dose or 'make up' for the missed shot on your own. The safety of immunotherapy depends on the timing between injections; if too much time passes, your sensitivity to the allergen may increase, making your previous dose potentially dangerous. Depending on how many weeks have passed, your doctor may need to repeat your last dose or even reduce the dose slightly for your next visit. Consistency is key to both the safety and the effectiveness of the desensitization process.
There is no clinical evidence to suggest that Canis Lupus Familiaris Skin allergenic extract causes weight gain. The extract consists of natural proteins and is administered in very small quantities that do not affect the body's metabolism, appetite, or fat storage. Unlike systemic corticosteroids (like prednisone), which are sometimes used to treat severe allergies and are known to cause weight gain, allergenic extracts work specifically on the immune system's recognition of proteins. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking. You should discuss any concerns about weight with your primary care physician.
Canis Lupus Familiaris Skin can be taken alongside most common medications, but there are some critical exceptions that you must discuss with your doctor. The most important interaction is with beta-blockers, which are often prescribed for heart conditions or high blood pressure, as they can make an allergic reaction more severe and harder to treat. Other medications like ACE inhibitors, MAO inhibitors, and certain antidepressants may also require special consideration. Most standard allergy medications, such as antihistamines and nasal steroids, are perfectly fine to use and may even be recommended by your allergist to manage symptoms during the buildup phase. Always provide your allergist with a complete and updated list of all medications and supplements you are using.
The concept of 'generic' vs. 'brand name' works differently for allergenic extracts than for traditional pills. Canis Lupus Familiaris Skin is a biological product, and various manufacturers produce their own versions of dog dander extracts. While these extracts all contain the same basic proteins, they are not necessarily identical or interchangeable. Your allergist will typically use a specific manufacturer's extract for your entire course of treatment to ensure consistency in potency. Because these are biological extracts rather than synthesized chemicals, they are generally referred to by their descriptive name rather than a brand name, although companies like Greer, ALK, and Stallergenes Greer are major producers.